Eagle Capital Growth【GRF】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

9.82

買値

売値

出来高

1,000

9.64 日の範囲 9.85

8.72 52 週間の範囲 10.99

時価総額

38.964M

前日終値

9.75

始値

9.64

時刻

100

9.82

最終取引時間

財務取引量

US$ 9,812

VWAP

9.8118

平均取引量 (3 か月)

6,731

発行済株式数

3,967,836

配当利回り

6.92%

PER

8.45

1 株当たり利益 (EPS)

1.16

歳入

736k

純利益

4.61M

The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments.

セクター

Unit Inv Tr, Closed-end Mgmt

業界

Unit Inv Tr, Closed-end Mgmt

本社

Lutherville Timonium, Maryland, USA

設立

Eagle Capital Growth Fund Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the アメリカ証券取引所 with ticker GRF. The last closing price for Eagle Capital Growth was US$9.75. Over the last year, Eagle Capital Growth shares have traded in a share price range of US$ 8.72 to US$ 10.99.

Eagle Capital Growth currently has 3,967,836 shares in issue. The market capitalisation of Eagle Capital Growth is US$38.69 million. Eagle Capital Growth has a price to earnings ratio (PE ratio) of 8.45.

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Form 4 - Statement of changes in beneficial ownership of securities

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and...

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

The Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) today declared a year-end distribution of $0.68 per share in cash. The record date for this distribution is November 29, 2024...

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management...

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare...

Form 4 - Statement of changes in beneficial ownership of securities

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s...

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.31	3.25972660358	9.51	10.28	9.51	1556	9.85676024	CS
4	0.34	3.5864978903	9.48	10.77	9.4	11379	10.05689169	CS
12	0.1	1.02880658436	9.72	10.99	8.85	6731	9.97872272	CS
26	0.46	4.91452991453	9.36	10.99	8.85	5013	9.82255101	CS
52	0.21	2.18522372529	9.61	10.99	8.72	3879	9.63003122	CS
156	0.09	0.924974306269	9.73	11.25	7.8	4678	9.1739904	CS
260	1.63	19.9023199023	8.19	11.25	5.2	4960	8.55206648	CS

GRF - Frequently Asked Questions (FAQ)

What is the current Eagle Capital Growth share price?

The current share price of Eagle Capital Growth is US$ 9.82

How many Eagle Capital Growth shares are in issue?

Eagle Capital Growth has 3,967,836 shares in issue

What is the market cap of Eagle Capital Growth?

The market capitalisation of Eagle Capital Growth is USD 38.69M

What is the 1 year trading range for Eagle Capital Growth share price?

Eagle Capital Growth has traded in the range of US$ 8.72 to US$ 10.99 during the past year

What is the PE ratio of Eagle Capital Growth?

The price to earnings ratio of Eagle Capital Growth is 8.45

What is the cash to sales ratio of Eagle Capital Growth?

The cash to sales ratio of Eagle Capital Growth is 52.94

What is the reporting currency for Eagle Capital Growth?

Eagle Capital Growth reports financial results in USD

What is the latest annual turnover for Eagle Capital Growth?

The latest annual turnover of Eagle Capital Growth is USD 736k

What is the latest annual profit for Eagle Capital Growth?

The latest annual profit of Eagle Capital Growth is USD 4.61M

What is the registered address of Eagle Capital Growth?

The registered address for Eagle Capital Growth is 2405 YORK ROAD, SUITE 201, LUTHERVILLE TIMONIUM, MARYLAND, 21093 2264

Which industry sector does Eagle Capital Growth operate in?

Eagle Capital Growth operates in the UNIT INV TR, CLOSED-END MGMT sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
KLIPKraneshares China Internet and Covered Call Strategy ETF	US$ 32.18 (197.41%)	206.71k
GRFXGraphex Group Limited	US$ 0.3996 (45.26%)	15.23M
AMBOAmbow Education Holding Ltd	US$ 2.95 (40.48%)	215.13k
IAUXi 80 Gold Corp	US$ 0.5979 (23.28%)	5.6M
BURUNuburu Inc	US$ 0.7972 (19.81%)	4.15M
KULRKULR Technology Group Inc	US$ 3.055 (-13.94%)	49.68M
TSLTT Rex 2X Long Tesla Daily Target ETF	US$ 33.26 (-12.20%)	5.16M
CTMCastellum Inc	US$ 1.761 (-11.95%)	8.51M
BEEPMobile Infrastructure Corporation	US$ 4.03 (-10.44%)	98.29k
SENSSenseonics Holdings Inc	US$ 0.4733 (-9.57%)	5.46M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.325 (0.72%)	123.47M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.79 (12.05%)	81.64M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.67 (1.32%)	80.47M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.12 (-6.02%)	58.88M
UVIX2x Long VIX Futures ETF	US$ 3.535 (3.97%)	56.16M